VRS
CLDX icon

Virginia Retirement Systems’s Celldex Therapeutics CLDX Stock Holding History

Virginia Retirement Systems’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14,000
Closed -$288K – 1034
2021
Q1 		$288K Buy
+14,000
New +$321K ﹤0.01% 1004
2018
Q2 		– Sell
-1,733
Closed -$61K – 1046
2018
Q1 		$61K Hold
1,733
– – ﹤0.01% 971
2017
Q4 		$74K Sell
1,733
-254
-13% -$10.9K ﹤0.01% 970
2017
Q3 		$85K Sell
1,987
-213
-10% -$7.98K ﹤0.01% 1006
2017
Q2 		$82K Sell
2,200
-60
-3% -$2.65K ﹤0.01% 1036
2017
Q1 		$122K Sell
2,260
-293
-11% -$15.3K ﹤0.01% 1094
2016
Q4 		$136K Buy
2,553
+73
+3% +$4.15K ﹤0.01% 951
2016
Q3 		$150K Buy
+2,480
New +$154K ﹤0.01% 907

Other funds holding CLDX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

Virginia Retirement Systems's CLDX Position: Q2 2021 in Review

Virginia Retirement Systems sold out of Celldex Therapeutics (CLDX) in Q2 2021, closing a stake of 14,000 shares — an estimated $288K sold.

Virginia Retirement Systems first reported a position in CLDX in Q3 2016 and held it in 8 quarters. The position peaked at $288K in Q1 2021. 131 funds tracked by Wall St. Rank hold CLDX as of Q2 2021.

  • Virginia Retirement Systems reported no remaining Celldex Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Virginia Retirement Systems sold 14,000 Celldex Therapeutics shares in Q2 2021, an estimated $288K.
  • Virginia Retirement Systems first reported a position in Celldex Therapeutics in Q3 2016 and held it in 8 quarters.
  • Virginia Retirement Systems's Celldex Therapeutics position peaked at $288K in Q1 2021.
  • 131 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q2 2021.

Based on Virginia Retirement Systems's 13F filing for Q2 2021, filed 13 Aug 2021.